Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAvivagen Inc

Avivagen Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
None CAD 0.00(0%)
Last update at 2024-07-24T14:02:55.313706Z
Market Cap
0.39M

Momentum Score

…

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.01
Low
0.12
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.01
Dividend Yield
-
Revenue TTM
0.72M
Revenue Per Share
0.01
Gross Profit TTM
0.40M
Debt / Equity
-
ROE
-
Net Debt
5.77M
ROCE
668.31%
Diluted EPS TTM
-0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Income before tax -6.07M -6.39M -4.75M -4.84M -4.83M
Net income -6.07M -6.39M -4.75M -4.84M -4.83M
Selling general administrative 1.90M 4.69M 4.33M 3.77M 4.27M
Gross profit 0.40M 0.53M 0.47M 0.53M 0.65M
Reconciled depreciation 0.09M 0.12M 0.13M 0.00M 0.00M
Ebit -4.90M -4.11M -3.39M -3.89M -4.15M
Ebitda -4.21M -4.68M -3.41M -4.11M -4.53M
Operating income -1.53M -4.11M -3.39M -3.89M -4.15M
Other operating expenses 0.05M 0.17M 0.60M 0.07M 0.07M
Interest expense 1.77M 1.59M 1.22M 0.73M 0.30M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.00M 0.00M 0.01M - -
Net interest income -1.17M -2.25M -1.34M -0.89M -0.44M
Income tax expense - - - - 0.00M
Total revenue 0.94M 1.30M 1.18M 0.98M 1.07M
Total operating expenses 2.47M 5.40M 4.56M 4.87M 5.22M
Cost of revenue 0.54M 0.76M 0.71M 0.45M 0.42M
Total other income expense net -3.36M -0.04M -0.03M -0.05M -0.25M
Net income from continuing ops -6.07M -6.39M -4.75M -4.84M -4.83M
Net income applicable to common shares -6.07M -6.39M -4.75M -4.84M -4.83M
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Total assets 1.37M 3.48M 2.18M 1.89M 3.11M
Other current assets 0.03M 0.03M - - -
Total liab 7.35M 7.43M 6.94M 5.14M 3.02M
Total stockholder equity -5.98M -3.95M -4.77M -3.26M 0.09M
Other current liab 0.06M 0.06M 0.03M 0.10M 0.11M
Common stock 34.90M 31.82M 26.56M 23.96M 22.96M
Capital stock 34.90M 31.82M 26.56M 23.96M 22.96M
Retained earnings -45.19M -40.47M -35.14M -31.01M -26.40M
Cash 0.29M 1.41M 0.66M 1.09M 2.21M
Total current liabilities 2.10M 6.01M 2.35M 1.30M 1.01M
Net debt 5.77M 5.30M 5.20M 3.50M 0.05M
Short term debt - - - 0.65M 0.14M
Short long term debt 0.81M 5.32M 1.36M 0.75M 0.25M
Other stockholder equity - - - 0.35M 0.25M
Property plant equipment 0.09M 0.26M 0.39M 0.17M 0.07M
Total current assets 1.27M 3.22M 1.78M 1.72M 3.04M
Net tangible assets -5.98M -3.95M -4.77M -3.26M 0.09M
Net receivables 0.57M 0.44M 0.61M 0.13M 0.23M
Long term debt 5.25M 1.40M 4.50M 3.84M 2.01M
Inventory 0.31M 1.23M 0.41M 0.45M 0.58M
Accounts payable 0.91M 0.46M 0.71M 0.51M 0.70M
Non currrent assets other - - - 0.17M 0.07M
Non current assets total 0.09M 0.26M 0.39M 0.17M 0.07M
Capital lease obligations 0.02M 0.09M 0.26M - -
Breakdown 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Type yearly yearly yearly yearly yearly
Date 2022-10-31 2021-10-31 2020-10-31 2019-10-31 2018-10-31
Investments 0.00M -0.01M -0.04M -0.11M -0.07M
Change to liabilities 0.64M -0.23M 0.23M -0.21M 0.26M
Total cashflows from investing activities - -0.01M -0.04M -0.11M -0.07M
Net borrowings -1.12M -0.86M 0.69M 2.16M 0.73M
Total cash from financing activities 2.00M 5.35M 2.96M 2.51M 4.48M
Change to operating activities 0.04M -0.04M -0.06M 0.13M 0.03M
Net income -6.07M -6.39M -4.75M -4.84M -4.83M
Change in cash -1.12M 0.74M -0.42M -1.12M 0.61M
Begin period cash flow 1.41M 0.66M 1.09M 2.21M 1.60M
End period cash flow 0.29M 1.41M 0.66M 1.09M 2.21M
Total cash from operating activities -3.12M -4.60M -3.34M -3.52M -3.81M
Issuance of capital stock 4.03M 7.50M 3.00M 1.08M 4.06M
Depreciation 0.09M 0.12M 0.13M 0.00M 0.00M
Dividends paid 0.00M 0.00M 0.00M 0.00M -
Change to inventory 0.22M -0.83M 0.05M -0.02M -0.49M
Change to account receivables -0.13M 0.17M -0.48M 0.09M -0.13M
Other cashflows from financing activities -0.91M -1.30M -0.77M -0.73M 0.41M
Change to netincome 2.09M 2.59M 1.54M 1.31M 1.32M
Capital expenditures 0.00M 0.01M 0.04M 0.11M 0.07M
Change in working capital 1.55M -0.92M -0.26M -0.00M -0.24M
Stock based compensation 0.15M 0.33M 0.32M 0.32M -
Other non cash items 1.06M 2.12M 1.09M 0.99M 0.69M
Free cash flow -3.12M -4.61M -3.38M -3.63M -3.88M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
RX
Biosyent Inc.		 0.30
1.78%		 17.15 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 0.21
11.67%		 2.01 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 0.03
9.38%		 0.35 - - 108.48 4.41 140.29 -4.26
LSL
LSL Pharma Group Inc.		 0.01
1.64%		 0.31 20.75 - 1.88 1.89 2.85 10.19

Profile*

Avivagen Inc

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

100 Sussex Drive, Ottawa, ON, Canada, K1A 0R6

613 702 2908

https://www.avivagen.com

Name Title Year Born
Mr. G. F. Kym Anthony CEO & Director 1956
Dr. Graham Burton Ph.D. Co-Founder, Chief Scientific Officer & Director NA
Dr. James Nickerson Ph.D. Pres and Exec. VP of Bus. Devel. & Product Innovation NA
Mr. Ira Levy Interim Chief Financial Officer NA
Mr. Drew Basek Director of Investor Relations NA
Ms. Tracy Gillett BVSC Director of Companion Animal & Marketing Mang. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

PRL
CAD 30.50
+15.05%
DSV
CAD 11.02
+14.55%
USA
CAD 4.29
+13.19%
NUAG
CAD 7.70
+12.90%
GMIN
CAD 43.79
+12.86%
DRUG
CAD 26.11
-29.58%
HUT
CAD 68.98
-22.41%
UCU
CAD 2.09
-14.34%
VET
CAD 14.87
-14.29%
PHX
CAD 10.96
-13.56%

Equity Sectors*

  • Basic Materials

    +5.46%

  • Communication Services

    +3.38%

  • Consumer Cyclical

    +3.11%

  • Consumer Defensive

    +1.35%

  • Energy

    -4.79%

  • Financial Services

    +2.66%

  • Healthcare

    -0.72%

  • Industrials

    -0.11%

  • Real Estate

    +1.84%

  • Technology

    +1.05%

  • Utilities

    +0.39%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…